Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease
Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease
Hyperphosphorylation of the microtubule-associated protein tau is a significant determinant in AD (Alzheimer's disease), where it is associated with disrupted axonal transport and probably causes synaptic dysfunction. Although less well studied, hyperphosphorylation has been observed in prion disease. We have investigated the expression of hyperphosphorylated tau in the hippocampus of mice infected with the ME7 prion agent. In ME7-infected animals, there is a selective loss of CA1 synapse, first discernable at 13 weeks of disease. There is a potential that dysfunctional axonal transport contributes to this synaptopathy. Thus investigating hyperphosphorylated tau that is dysfunctional in AD could illuminate whether and how they are significant in prion disease. We observed no differences in the levels of phosphorylated tau (using MC1, PHF-1 and CP13 antibodies) in detergent-soluble and detergent-insoluble fractions extracted from ME7- and NBH- (normal brain homogenate) treated animals across disease. In contrast, we observed an increase in phospho-tau staining for several epitopes using immunohistochemistry in ME7-infected hippocampal sections. Although the changes were not of the magnitude seen in AD tissue, clear differences for several phospho-tau species were seen in the CA1 and CA3 of ME7-treated animals (pSer(199-202)>pSer(214)>PHF-1 antibody). Temporally, these changes were restricted to animals at 20 weeks and none of the disease-related staining was associated with the axons or dendrites that hold CA1 synapses. These findings suggest that phosphorylation of tau at the epitopes examined does not underpin the early synaptic dysfunction. These data suggest that the changes in tau phosphorylation recorded here and observed by others relate to end-stage prion pathology when early dysfunctions have progressed to overt neuronal loss.
545-551
Asuni, Ayodeji A.
b1412b1b-9794-4705-aada-aed5d3da038f
Perry, V. Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
O'Connor, Vincent
8021b06c-01a0-4925-9dde-a61c8fe278ca
April 2010
Asuni, Ayodeji A.
b1412b1b-9794-4705-aada-aed5d3da038f
Perry, V. Hugh
8f29d36a-8e1f-4082-8700-09483bbaeae4
O'Connor, Vincent
8021b06c-01a0-4925-9dde-a61c8fe278ca
Asuni, Ayodeji A., Perry, V. Hugh and O'Connor, Vincent
(2010)
Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.
Biochemical Society Transactions, 38 (2), .
(doi:10.1042/BST0380545).
(PMID:20298219)
Abstract
Hyperphosphorylation of the microtubule-associated protein tau is a significant determinant in AD (Alzheimer's disease), where it is associated with disrupted axonal transport and probably causes synaptic dysfunction. Although less well studied, hyperphosphorylation has been observed in prion disease. We have investigated the expression of hyperphosphorylated tau in the hippocampus of mice infected with the ME7 prion agent. In ME7-infected animals, there is a selective loss of CA1 synapse, first discernable at 13 weeks of disease. There is a potential that dysfunctional axonal transport contributes to this synaptopathy. Thus investigating hyperphosphorylated tau that is dysfunctional in AD could illuminate whether and how they are significant in prion disease. We observed no differences in the levels of phosphorylated tau (using MC1, PHF-1 and CP13 antibodies) in detergent-soluble and detergent-insoluble fractions extracted from ME7- and NBH- (normal brain homogenate) treated animals across disease. In contrast, we observed an increase in phospho-tau staining for several epitopes using immunohistochemistry in ME7-infected hippocampal sections. Although the changes were not of the magnitude seen in AD tissue, clear differences for several phospho-tau species were seen in the CA1 and CA3 of ME7-treated animals (pSer(199-202)>pSer(214)>PHF-1 antibody). Temporally, these changes were restricted to animals at 20 weeks and none of the disease-related staining was associated with the axons or dendrites that hold CA1 synapses. These findings suggest that phosphorylation of tau at the epitopes examined does not underpin the early synaptic dysfunction. These data suggest that the changes in tau phosphorylation recorded here and observed by others relate to end-stage prion pathology when early dysfunctions have progressed to overt neuronal loss.
Text
Asuni_0380545.pdf
- Version of Record
More information
Published date: April 2010
Identifiers
Local EPrints ID: 180209
URI: http://eprints.soton.ac.uk/id/eprint/180209
ISSN: 0300-5127
PURE UUID: 3776a55c-3d23-40f5-9e9c-c02e8d6fe171
Catalogue record
Date deposited: 06 Apr 2011 10:44
Last modified: 15 Mar 2024 03:04
Export record
Altmetrics
Contributors
Author:
Ayodeji A. Asuni
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics